Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 20 of 20 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/19/23
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 05/10/23
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 11/14/18
End: 09/03/20
Due: 09/03/21
Phase: N/A
Priority: Normal
Start: 07/03/20
End: 03/25/24
Due: 03/25/25
Phase: N/A
Priority: Normal
Start: 03/12/25
End: 05/31/31
Due: 05/31/32
Phase: N/A
Priority: Normal
Start: 08/26/19
End: 11/01/21
Due: 11/01/22
Phase: N/A
Priority: Normal
Start: 09/17/22
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 10/30/22
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 12/28/20
End: 12/05/22
Due: 12/05/23
Phase: N/A
Priority: Normal
Start: 05/26/20
End: 11/25/22
Due: 11/25/23
A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 04/21/25
Due: 04/21/26
Phase: N/A
Priority: Normal
Start: 09/21/22
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 02/18/21
End: 04/06/22
Due: 04/06/23
Phase: N/A
Priority: Normal
Start: 07/06/21
End: 12/07/21
Due: 12/07/22
Phase: N/A
Priority: Normal
Start: 06/10/21
End: 03/24/23
Due: 03/24/24
Phase: N/A
Priority: Normal
Start: 07/11/21
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/27/20
End: 09/02/21
Due: 09/02/22
Phase: N/A
Priority: Normal
Start: 03/28/22
End: 11/06/23
Due: 11/06/24